These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 34953774)

  • 21. Do you approve of spending $300 million on HPV vaccination?: no.
    Lippman A; Boscoe M; Scurfield C
    Can Fam Physician; 2008 Feb; 54(2):175, 177, 179, 181. PubMed ID: 18272623
    [No Abstract]   [Full Text] [Related]  

  • 22. [Cervix carcinoma--Austrian Vaccination Committee recommends HPV vaccination].
    Six L; Joura EA
    Wien Med Wochenschr; 2007; 157(5-6):130-2. PubMed ID: 17427010
    [No Abstract]   [Full Text] [Related]  

  • 23. I want the one for older women - extending the human papillomavirus vaccine population base.
    Wain GV
    Med J Aust; 2008 May; 188(9):501-2. PubMed ID: 18459918
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HPV vaccines and cervical cancer.
    Bosch FX
    Ann Oncol; 2008 Jul; 19 Suppl 5():v48-51. PubMed ID: 18611900
    [No Abstract]   [Full Text] [Related]  

  • 25. HPV vaccine: a cornerstone of female health.
    Temte JL
    Am Fam Physician; 2007 Jan; 75(1):28, 30. PubMed ID: 17225700
    [No Abstract]   [Full Text] [Related]  

  • 26. Primary strategies for HPV infection and cervical cancer prevention.
    Harper DM; Demars LR
    Clin Obstet Gynecol; 2014 Jun; 57(2):256-78. PubMed ID: 24686336
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Human papillomavirus vaccination : pharmacovigilance data].
    Dib F; Launay O
    Rev Prat; 2020 Jan; 70(1):96-98. PubMed ID: 32877039
    [No Abstract]   [Full Text] [Related]  

  • 28. Towards global prevention of human papillomavirus-induced cancer.
    Roden RB; Gravitt P; Wu TC
    Eur J Immunol; 2008 Feb; 38(2):323-6. PubMed ID: 18228245
    [No Abstract]   [Full Text] [Related]  

  • 29. Quadrivalent Human Papillomavirus Vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP).
    Markowitz LE; Dunne EF; Saraiya M; Lawson HW; Chesson H; Unger ER; ;
    MMWR Recomm Rep; 2007 Mar; 56(RR-2):1-24. PubMed ID: 17380109
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epidemiology of human papillomavirus infection and cervical cancer and future perspectives in Hong Kong, Singapore and Taiwan.
    Tay SK; Ngan HY; Chu TY; Cheung AN; Tay EH
    Vaccine; 2008 Aug; 26 Suppl 12():M60-70. PubMed ID: 18945415
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Cervical HPV infection; epidemiology and vaccination].
    Yoshikawa H
    Kansenshogaku Zasshi; 2008 Nov; 82(6):609-12. PubMed ID: 19086414
    [No Abstract]   [Full Text] [Related]  

  • 32. Real-World Effectiveness of Human Papillomavirus Vaccination Against Cervical Cancer.
    Kjaer SK; Dehlendorff C; Belmonte F; Baandrup L
    J Natl Cancer Inst; 2021 Oct; 113(10):1329-1335. PubMed ID: 33876216
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Low affordability may limit the effect of cervical cancer vaccination in central and eastern European countries.
    Zubor P; Danko J; Kajo K; Szunyogh N
    J Clin Oncol; 2007 Dec; 25(34):5534-7. PubMed ID: 18048836
    [No Abstract]   [Full Text] [Related]  

  • 34. Experts say that cervical cancer could be eliminated worldwide with screening, human papillomavirus vaccine.
    Printz C
    Cancer; 2020 Aug; 126(15):3387. PubMed ID: 32633871
    [No Abstract]   [Full Text] [Related]  

  • 35. Primary and secondary prevention of cervical cancer--opportunities and challenges.
    Markowitz LE; Unger ER; Saraiya M
    J Natl Cancer Inst; 2009 Apr; 101(7):439-40. PubMed ID: 19318638
    [No Abstract]   [Full Text] [Related]  

  • 36. The impact of cytology screening and HPV vaccination on the burden of cervical cancer.
    Tay K; Tay SK
    Asia Pac J Clin Oncol; 2011 Jun; 7(2):154-9. PubMed ID: 21585695
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HPV vaccination associated with decreased cervical cancer incidence and mortality.
    Caskey R
    J Pediatr; 2022 Jun; 245():246-249. PubMed ID: 35718380
    [No Abstract]   [Full Text] [Related]  

  • 38. [Recommendations for the definition of a policy on vaccination against papillomavirus in Mexico. Strategic Advisory Group of Experts of the World Health Organization].
    Lazcano-Ponce E; Salmerón-Castro J; García-Carrancá A; Aranda-Flores C; Madrid-Marina V; Gómez-Altamirano CM; Martínez-Montañez OG
    Salud Publica Mex; 2009; 51(4):336-41. PubMed ID: 19668929
    [No Abstract]   [Full Text] [Related]  

  • 39. Mathematical analysis of a human papillomavirus transmission model with vaccination and screening.
    Zhang K; Wang XW; Liu H; Ji YP; Pan QW; Wei YM; Ma M
    Math Biosci Eng; 2020 Aug; 17(5):5449-5476. PubMed ID: 33120561
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vaccination against human papillomavirus.
    Mello CF
    Einstein (Sao Paulo); 2013 Dec; 11(4):547-9. PubMed ID: 24488402
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.